Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. Abstract Text:

    boryana k popivanovaBoryana K Popivanova,kazuya kitamuraKazuya Kitamura,yu wuYu Wu,toshikazu kondoToshikazu Kondo,takashi kagayaTakashi Kagaya,shiuchi kanekoShiuchi Kaneko,masanobu oshimaMasanobu Oshima,chifumi fujiiChifumi Fujii,naofumi mukaidaNaofumi Mukaida,

    The inflammatory bowel disease ulcerative colitis (UC) frequently progresses to colon cancer. To understand the mechanisms by which UC patients develop colon carcinomas, we used a mouse model of the disease whereby administration of azoxymethane (AOM) followed by repeated dextran sulfate sodium (DSS) ingestion causes severe colonic inflammation and the subsequent development of multiple tumors. We found that treating WT mice with AOM and DSS increased TNF-alpha expression and the number of infiltrating leukocytes expressing its major receptor, p55 (TNF-Rp55), in the lamina propria and submucosal regions of the colon. This was followed by the development of multiple colonic tumors. Mice lacking TNF-Rp55 and treated with AOM and DSS showed reduced mucosal damage, reduced infiltration of macrophages and neutrophils, and attenuated subsequent tumor formation. WT mice transplanted with TNF-Rp55-deficient bone marrow also developed significantly fewer tumors after AOM and DSS treatment than either WT mice or TNF-Rp55-deficient mice transplanted with WT bone marrow. Furthermore, administration of etanercept, a specific antagonist of TNF-alpha, to WT mice after treatment with AOM and DSS markedly reduced the number and size of tumors and reduced colonic infiltration by neutrophils and macrophages. These observations identify TNF-alpha as a crucial mediator of the initiation and progression of colitis-associated colon carcinogenesis and suggest that targeting TNF-alpha may be useful in treating colon cancer in individuals with UC.

    Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. Publishing Authors By Initials

    bk popivanovaBK Popivanova,k kitamuraK Kitamura,y wuY Wu,t kondoT Kondo,t kagayaT Kagaya,s kanekoS Kaneko,m oshimaM Oshima,c fujiiC Fujii,n mukaidaN Mukaida,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: The Journal of clinical investigation

    VOLUME: 118

    Page Numbers: 560-70

    Journal Abbreviation: J. Clin. Invest.

    ISSN: 0021-9738

    DAY: 4

    MONTH: Feb

    YEAR: 2008

    Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7802877

    Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

    AFFILIATION: Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Clin Invest

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News